Europeiska unionen - svenska - EMA (European Medicines Agency)

astellas pharma europe b.v. - mirabegron - urinblåsan, overaktiv - urologiska - symptomatisk behandling av brådskande. Ökad urinering frekvens och / eller brådskande inkontinens som kan förekomma hos vuxna patienter med överaktiv urinblåsa syndrom.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - digoxin - oral lösning - 50 mikrogram/ml - digoxin 50 mikrog aktiv substans; sackaros hjälpämne; propylenglykol hjälpämne; metylparahydroxibensoat hjälpämne; etanol, vattenfri hjälpämne - digoxin

Europeiska unionen - svenska - EMA (European Medicines Agency)

sanofi b.v. - eliglustat - gauchersjukdom - andra matsmältningsorgan och ämnesomsättning produkter, - cerdelga är indicerat för långsiktig behandling av vuxna patienter med gauchers sjukdom typ 1 (gd1), som är cyp2d6-metaboliserare (pms), mellanliggande metaboliserare (ims) eller metaboliserare (ems).

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - digoxin - tablett - 0,13 mg - laktosmonohydrat hjälpämne; glycerol hjälpämne; digoxin 0,13 mg aktiv substans - digoxin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - digoxin - tablett - 0,25 mg - digoxin 0,25 mg aktiv substans; laktosmonohydrat hjälpämne; glycerol hjälpämne - digoxin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - digoxin - injektionsvätska, lösning - 0,25 mg/ml - digoxin 0,25 mg aktiv substans; propylenglykol hjälpämne; etanol, vattenfri hjälpämne - digoxin

Europeiska unionen - svenska - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aristo pharma gmbh - abirateronacetat - filmdragerad tablett - 500 mg - abirateronacetat 500 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne